Coherus Oncology
CHRS
CHRS
94 hedge funds and large institutions have $436M invested in Coherus Oncology in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $627M → $436M (-$191M)
41% less call options, than puts
Call options by funds: $590K | Put options by funds: $1.01M
Holders
94
Holding in Top 10
–
Calls
$590K
Puts
$1.01M
Top Buyers
| 1 | +$13.9M | |
| 2 | +$8.6M | |
| 3 | +$5.49M | |
| 4 |
O
OrbiMed
New York
|
+$3.45M |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$3.35M |
Top Sellers
| 1 | -$9.72M | |
| 2 | -$8.99M | |
| 3 | -$5.17M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.57M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.94M |